Federal contractor · WEST SACRAMENTO, CA

GEMINI BIOPRODUCTS LLC

GEMINI BIOPRODUCTS LLC received -$160 in federal contract obligations in FY2026, on 1 awards (−100% vs FY2025). Since FY2017: $4.9M. Its largest customer was National Institutes of Health (-$160).

Obligations · FY2026
-$160
New awards
1
Sole-source
—
Single offer
—
UEI
TPLGWKT6AM88
Parent company
UNIPACK, INC.
Other than small business
Open in the contracts explorerRelationship graph

Company family

Grouped from reported parent companies (UEI) and, where marked, AI judgments that two records name the same organization or group.

3 registered entities of the same company or corporate group, -$160 in FY2026 together.

  1. GEMINI BIOPRODUCTS LLCWEST SACRAMENTO, CA · Family page
    -$160
  2. EI SPECTRA, LLCHAILEY, ID
    $0
  3. ORFLO TECHNOLOGIES, LLCKETCHUM, ID
    $0

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 243.2KFY2017
  2. 351.1KFY2018
  3. 63.3KFY2019
  4. 3.7MFY2020
  5. 277.8KFY2021
  6. 23.1KFY2022
  7. 43.2KFY2023
  8. 141KFY2024
  9. 63.5KFY2025
  10. -159.6FY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health-$1600.0%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Largest awards

  1. BENCHMARK FETAL BOVINE SERUM - 500ML$24.8K
    National Institutes of Health· Yolo County, CA· Health & medical· Dec 3, 2020 – Sep 4, 2026· 75N93021P00125

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. MEDUNIK USA INC$210K
    PRINCETON, NJ · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  2. ADC THERAPEUTICS AMERICA, INC.$194K−100% in FY2026
    NEW PROVIDENCE, NJ · 95% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  3. DNA TWOPOINTO INC.$225K0% in FY2026
    NEWARK, CA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.